Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2023 Filed Sep 8, 2023 19:16 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 2,553 | $0.79 | $2,023.25 |
DisclosureSEC source: 0001437749-23-025519 · rdgdoc.xml · nonDerivative · entry 2 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By self as trustee of the Michael Arlen Davis Revocable Trust Disclosed balance after: 585,318 F2 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.77 to $0.80, inclusive. Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 19:16 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 17,900 | $0.75 | $13,351.61 |
DisclosureSEC source: 0001437749-23-025519 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By self as trustee of the Michael Arlen Davis Revocable Trust Disclosed balance after: 582,765 F1 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.70 to $0.75, inclusive. The reporting person undertakes to provide to Cyanotech Corporation, any security holder of Cyanotech Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote 2. Read SEC document |
| September 06, 2023 Filed Sep 7, 2023 15:54 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 5,847 | $0.69 | $4,043.20 |
DisclosureSEC source: 0001437749-23-025387 · rdgdoc.xml · nonDerivative · entry 2 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By self as trustee of the Michael Arlen Davis Revocable Trust Disclosed balance after: 564,865 F2 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.65 to $0.70, inclusive. Read SEC document |
| September 05, 2023 Filed Sep 7, 2023 15:54 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
PurchaseCyanotech Corporation Common Stock | 12,673 | $0.66 | $8,309.69 |
DisclosureSEC source: 0001437749-23-025387 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By self as trustee of the Michael Arlen Davis Revocable Trust Disclosed balance after: 559,018 F1 · price: The price reported is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.65 to $0.67, inclusive. The reporting person undertakes to provide to Cyanotech Corporation, any security holder of Cyanotech Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote 2. Read SEC document |
| August 25, 2023 Filed Aug 28, 2023 15:23 UTC |
McElwee Angela MayDirector
|
GrantCyanotech Corporation Common Stock | 40,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-024761 · rdgdoc.xml · nonDerivative · entry 1 McElwee Angela May · CIK 0001893489 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,567 Read SEC document |
| August 25, 2023 Filed Aug 28, 2023 15:20 UTC |
MULDER DAVID MDirector
|
GrantCyanotech Corporation Common Stock | 40,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-024758 · rdgdoc.xml · nonDerivative · entry 1 MULDER DAVID M · CIK 0001208781 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,962 Read SEC document |
| August 25, 2023 Filed Aug 28, 2023 15:17 UTC |
Vied David LDirector
|
GrantCyanotech Corporation Common Stock | 40,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-024756 · rdgdoc.xml · nonDerivative · entry 1 Vied David L · CIK 0001632792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,632 Read SEC document |
| August 25, 2023 Filed Aug 28, 2023 15:10 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
GrantCyanotech Corporation Common Stock | 37,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-024754 · rdgdoc.xml · nonDerivative · entry 2 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By self as trustee of the Michael Arlen Davis Revocable Trust Disclosed balance after: 546,345 Read SEC document |
| August 24, 2023 Filed Aug 28, 2023 15:10 UTC |
DAVIS MICHAEL A /Director · 10% owner
|
GiftCyanotech Corporation Common Stock | 424,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-024754 · rdgdoc.xml · nonDerivative · entry 1 DAVIS MICHAEL A / · CIK 0001201156 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By self as director of Skywords Family Foundation Inc. Disclosed balance after: 0 F1 · ownership.nature: Skywords is a 501(c)(3) charitable foundation, of which the Reporting Person and his spouse serve as the two directors. The Reporting Person should not be deemed to be a beneficial owner of the shares held by Skywords under Rule 16a-2, however, the shares held by Skywords are included here for purposes of complete disclosure and in light of such shares having been previously disclosed on previous Forms 4 filed by the Reporting Person. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:31 UTC |
Nordin Amy BethVP, HR, Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 1,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021390 · rdgdoc.xml · derivative · entry 3 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,104 Underlying: Common Stock · 1,904 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,502 shares on July 29, 2024; 33 shares on April 6, 2025; 1,502 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,502 shares on July 29, 2024; 33 shares on April 6, 2025; 1,502 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:31 UTC |
Nordin Amy BethVP, HR, Secretary
|
Tax withholdingCommon Stock | 716 | $0.84 | $601.44 |
DisclosureSEC source: 0001437749-23-021390 · rdgdoc.xml · nonDerivative · entry 2 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,761 F2 · kind: No stock was sold. On July 31, 2023, in connection with the vesting of 1,904 shares of stock, the Company withheld a total of 716 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:31 UTC |
Nordin Amy BethVP, HR, Secretary
|
Exercise / conversionCommon Stock | 1,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021390 · rdgdoc.xml · nonDerivative · entry 1 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:26 UTC |
Hartmann Charles JasonVP, Sales & Marketing
|
Exercise / conversionRestricted Stock Units · Derivative | 1,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021386 · rdgdoc.xml · derivative · entry 3 Hartmann Charles Jason · CIK 0001876043 · VP, Sales & Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,461 Underlying: Common Stock · 1,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,680 shares on July 29, 2024; 33 shares on April 6, 2025; 1,681 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,680 shares on July 29, 2024; 33 shares on April 6, 2025; 1,681 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:26 UTC |
Hartmann Charles JasonVP, Sales & Marketing
|
Tax withholdingCommon Stock | 670 | $0.84 | $562.80 |
DisclosureSEC source: 0001437749-23-021386 · rdgdoc.xml · nonDerivative · entry 2 Hartmann Charles Jason · CIK 0001876043 · VP, Sales & Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,049 F2 · kind: No stock was sold. On July 31, 2023, in connection with the vesting of 1,680 shares of stock, the Company withheld a total of 670 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:26 UTC |
Hartmann Charles JasonVP, Sales & Marketing
|
Exercise / conversionCommon Stock | 1,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021386 · rdgdoc.xml · nonDerivative · entry 1 Hartmann Charles Jason · CIK 0001876043 · VP, Sales & Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:21 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Exercise / conversionRestricted Stock Units · Derivative | 1,877 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021384 · rdgdoc.xml · derivative · entry 3 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,859 Underlying: Common Stock · 1,877 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,379 shares on July 30, 2024; 33 shares on April 6, 2025; 1,380 shares on July 30, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,379 shares on July 30, 2024; 33 shares on April 6, 2025; 1,380 shares on July 30, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:21 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Tax withholdingCommon Stock | 706 | $0.84 | $593.04 |
DisclosureSEC source: 0001437749-23-021384 · rdgdoc.xml · nonDerivative · entry 2 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,983 F2 · kind: No stock was sold. On July 31, 2023, in connection with the vesting of 1,877 shares of stock, the Company withheld a total of 706 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:21 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Exercise / conversionCommon Stock | 1,877 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021384 · rdgdoc.xml · nonDerivative · entry 1 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:17 UTC |
Jensen GlennVP, Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 2,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021381 · rdgdoc.xml · derivative · entry 4 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,383 Underlying: Common Stock · 2,206 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,641 shares on July 30, 2024; 33 shares on April 6, 2025; 1,642 shares on July 30, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,641 shares on July 30, 2024; 33 shares on April 6, 2025; 1,642 shares on July 30, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:17 UTC |
Jensen GlennVP, Operations
|
Tax withholdingCommon Stock | 830 | $0.84 | $697.20 |
DisclosureSEC source: 0001437749-23-021381 · rdgdoc.xml · nonDerivative · entry 2 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,561 F2 · kind: No stock was sold. On July 31, 2023, in connection with the vesting of 2,206 shares of stock, the Company withheld a total of 830 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:17 UTC |
Jensen GlennVP, Operations
|
Exercise / conversionCommon Stock | 2,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021381 · rdgdoc.xml · nonDerivative · entry 1 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:12 UTC |
Ladin Felicia ICFO, VP Fin & Admin, Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021377 · rdgdoc.xml · derivative · entry 3 Ladin Felicia I · CIK 0001632868 · CFO, VP Fin & Admin, Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,594 Underlying: Common Stock · 1,747 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,747 shares on July 29, 2024; 33 shares on April 6, 2025; 1,747 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,747 shares on July 29, 2024; 33 shares on April 6, 2025; 1,747 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:12 UTC |
Ladin Felicia ICFO, VP Fin & Admin, Treasurer
|
Tax withholdingCommon Stock | 656 | $0.84 | $551.04 |
DisclosureSEC source: 0001437749-23-021377 · rdgdoc.xml · nonDerivative · entry 2 Ladin Felicia I · CIK 0001632868 · CFO, VP Fin & Admin, Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,132 F2 · kind: No stock was sold. On July 31 2023, in connection with the vesting of 1,747 shares of stock, the Company withheld a total of 656 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:12 UTC |
Ladin Felicia ICFO, VP Fin & Admin, Treasurer
|
Exercise / conversionCommon Stock | 1,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021377 · rdgdoc.xml · nonDerivative · entry 1 Ladin Felicia I · CIK 0001632868 · CFO, VP Fin & Admin, Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:09 UTC |
Custer Matthew KeithDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 2,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021372 · rdgdoc.xml · derivative · entry 3 Custer Matthew Keith · CIK 0001789455 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,249 Underlying: Common Stock · 2,603 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2024; 2,074 shares on July 29, 2024; 33 shares on April 6, 2025; 2,075 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2024; 2,074 shares on July 29, 2024; 33 shares on April 6, 2025; 2,075 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:09 UTC |
Custer Matthew KeithDirector · President and CEO
|
Tax withholdingCommon Stock | 978 | $0.84 | $821.52 |
DisclosureSEC source: 0001437749-23-021372 · rdgdoc.xml · nonDerivative · entry 2 Custer Matthew Keith · CIK 0001789455 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,331 F2 · kind: No stock was sold. On July 31, 2023, in connection with the vesting of 2,603 shares of stock, the Company withheld a total of 978 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:09 UTC |
Custer Matthew KeithDirector · President and CEO
|
Exercise / conversionCommon Stock | 2,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021372 · rdgdoc.xml · nonDerivative · entry 1 Custer Matthew Keith · CIK 0001789455 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:04 UTC |
Cysewski Gerald RChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021368 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,253 Underlying: Common Stock · 2,243 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:04 UTC |
Cysewski Gerald RChief Scientific Officer
|
Tax withholdingCommon Stock | 843 | $0.84 | $708.12 |
DisclosureSEC source: 0001437749-23-021368 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,817 F2 · kind: No stock was sold. On July 31, 2023, in connection with the vesting of 2,243 shares of stock, the Company withheld a total of 843 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:04 UTC |
Cysewski Gerald RChief Scientific Officer
|
Exercise / conversionCommon Stock | 2,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021368 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 15:06 UTC |
Nordin Amy BethVP, HR, Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009825 · rdgdoc.xml · derivative · entry 4 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,008 Underlying: Common Stock · 34 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 1,501 shares at July 29, 2023; 403 shares at July 30, 2023; 33 shares on April 6, 2024; 1,502 shares on July 29, 2024; 33 shares on April 6, 2025; 1,502 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 1,501 shares at July 29, 2023; 403 shares at July 30, 2023; 33 shares on April 6, 2024; 1,502 shares on July 29, 2024; 33 shares on April 6, 2025; 1,502 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 15:06 UTC |
Nordin Amy BethVP, HR, Secretary
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009825 · rdgdoc.xml · derivative · entry 3 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,042 Underlying: Common Stock · 100 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,501 shares at July 29, 2023; 403 shares at July 30, 2023; 33 shares on April 6, 2024; 1,502 shares on July 29, 2024; 33 shares on April 6, 2025; 1,502 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,501 shares at July 29, 2023; 403 shares at July 30, 2023; 33 shares on April 6, 2024; 1,502 shares on July 29, 2024; 33 shares on April 6, 2025; 1,502 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 15:06 UTC |
Nordin Amy BethVP, HR, Secretary
|
Tax withholdingCommon Stock | 13 | $0.94 | $12.22 |
DisclosureSEC source: 0001437749-23-009825 · rdgdoc.xml · nonDerivative · entry 2 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,573 F2 · kind: No stock was sold. On April 6, 2023, in connection with the vesting of 34 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 15:06 UTC |
Nordin Amy BethVP, HR, Secretary
|
Exercise / conversionCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009825 · rdgdoc.xml · nonDerivative · entry 1 Nordin Amy Beth · CIK 0001789253 · VP, HR, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:59 UTC |
Jensen GlennVP, Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009817 · rdgdoc.xml · derivative · entry 5 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,589 Underlying: Common Stock · 34 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 1,641 shares on July 29, 2023; 565 shares on July 30, 2023; 33 shares on April 6, 2024; 1,641 shares on July 30, 2024; 33 shares on April 6, 2025; 1,642 shares on July 30, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 1,641 shares on July 29, 2023; 565 shares on July 30, 2023; 33 shares on April 6, 2024; 1,641 shares on July 30, 2024; 33 shares on April 6, 2025; 1,642 shares on July 30, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:59 UTC |
Jensen GlennVP, Operations
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009817 · rdgdoc.xml · derivative · entry 4 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,623 Underlying: Common Stock · 100 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,641 shares on July 29, 2023; 565 shares on July 30, 2023; 33 shares on April 6, 2024; 1,641 shares on July 30, 2024; 33 shares on April 6, 2025; 1,642 shares on July 30, 2025, and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,641 shares on July 29, 2023; 565 shares on July 30, 2023; 33 shares on April 6, 2024; 1,641 shares on July 30, 2024; 33 shares on April 6, 2025; 1,642 shares on July 30, 2025, and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:59 UTC |
Jensen GlennVP, Operations
|
Tax withholdingCommon Stock | 13 | $0.94 | $12.22 |
DisclosureSEC source: 0001437749-23-009817 · rdgdoc.xml · nonDerivative · entry 2 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,185 F2 · kind: No stock was sold. On April 6, 2023, in connection with the vesting of 34 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:59 UTC |
Jensen GlennVP, Operations
|
Exercise / conversionCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009817 · rdgdoc.xml · nonDerivative · entry 1 Jensen Glenn · CIK 0001369173 · VP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 15:04 UTC |
Hartmann Charles JasonVP, Sales & Marketing
|
Exercise / conversionRestricted Stock Units · Derivative | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009822 · rdgdoc.xml · derivative · entry 4 Hartmann Charles Jason · CIK 0001876043 · VP, Sales & Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,141 Underlying: Common Stock · 34 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 1,680 shares on July 29, 2023; 33 shares on April 6, 2024; 1,680 shares on July 29, 2024; 33 shares on April 6, 2025; 1,681 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 1,680 shares on July 29, 2023; 33 shares on April 6, 2024; 1,680 shares on July 29, 2024; 33 shares on April 6, 2025; 1,681 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 15:04 UTC |
Hartmann Charles JasonVP, Sales & Marketing
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009822 · rdgdoc.xml · derivative · entry 3 Hartmann Charles Jason · CIK 0001876043 · VP, Sales & Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,175 Underlying: Common Stock · 100 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,680 shares on July 29, 2023; 33 shares on April 6, 2024; 1,680 shares on July 29, 2024; 33 shares on April 6, 2025; 1,681 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,680 shares on July 29, 2023; 33 shares on April 6, 2024; 1,680 shares on July 29, 2024; 33 shares on April 6, 2025; 1,681 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 15:04 UTC |
Hartmann Charles JasonVP, Sales & Marketing
|
Tax withholdingCommon Stock | 14 | $0.94 | $13.16 |
DisclosureSEC source: 0001437749-23-009822 · rdgdoc.xml · nonDerivative · entry 2 Hartmann Charles Jason · CIK 0001876043 · VP, Sales & Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39 F2 · kind: No stock was sold. On April 6, 2023, in connection with the vesting of 34 shares of stock, the Company withheld a total of 14 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 15:04 UTC |
Hartmann Charles JasonVP, Sales & Marketing
|
Exercise / conversionCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009822 · rdgdoc.xml · nonDerivative · entry 1 Hartmann Charles Jason · CIK 0001876043 · VP, Sales & Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 15:02 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Exercise / conversionRestricted Stock Units · Derivative | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009820 · rdgdoc.xml · derivative · entry 4 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,736 Underlying: Common Stock · 34 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 1,379 shares on July 29, 2023; 498 shares on July 30, 2023; 33 shares on April 6, 2024; 1,379 shares on July 30, 2024; 33 shares on April 6, 2025; 1,380 shares on July 30, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 1,379 shares on July 29, 2023; 498 shares on July 30, 2023; 33 shares on April 6, 2024; 1,379 shares on July 30, 2024; 33 shares on April 6, 2025; 1,380 shares on July 30, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 15:02 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009820 · rdgdoc.xml · derivative · entry 3 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,770 Underlying: Common Stock · 100 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,379 shares on July 29, 2023; 498 shares on July 30, 2023; 33 shares on April 6, 2024; 1,379 shares on July 30, 2024; 33 shares on April 6, 2025; 1,380 shares on July 30, 2025, and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,379 shares on July 29, 2023; 498 shares on July 30, 2023; 33 shares on April 6, 2024; 1,379 shares on July 30, 2024; 33 shares on April 6, 2025; 1,380 shares on July 30, 2025, and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 15:02 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Tax withholdingCommon Stock | 13 | $0.94 | $12.22 |
DisclosureSEC source: 0001437749-23-009820 · rdgdoc.xml · nonDerivative · entry 2 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,812 F2 · kind: No stock was sold. On April 6, 2023, in connection with the vesting of 34 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 15:02 UTC |
Johansen Jennifer M.VP, Quality, Regulatory & Govt
|
Exercise / conversionCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009820 · rdgdoc.xml · nonDerivative · entry 1 Johansen Jennifer M. · CIK 0001725658 · VP, Quality, Regulatory & Govt 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:56 UTC |
Ladin Felicia ICFO, VP Fin & Admin, Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009815 · rdgdoc.xml · derivative · entry 4 Ladin Felicia I · CIK 0001632868 · CFO, VP Fin & Admin, Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,341 Underlying: Common Stock · 34 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 1,747 shares on July 29, 2023; 33 shares on April 6, 2024; 1,747 shares on July 29, 2024; 33 shares on April 6, 2025; 1,747 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 1,747 shares on July 29, 2023; 33 shares on April 6, 2024; 1,747 shares on July 29, 2024; 33 shares on April 6, 2025; 1,747 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:56 UTC |
Ladin Felicia ICFO, VP Fin & Admin, Treasurer
|
GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009815 · rdgdoc.xml · derivative · entry 3 Ladin Felicia I · CIK 0001632868 · CFO, VP Fin & Admin, Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,375 Underlying: Common Stock · 100 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vests as to 34 shares on April 6, 2023; 1,747 shares on July 29, 2023; 33 shares on April 6, 2024; 1,747 shares on July 29, 2024; 33 shares on April 6, 2025; 1,747 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vests as to 34 shares on April 6, 2023; 1,747 shares on July 29, 2023; 33 shares on April 6, 2024; 1,747 shares on July 29, 2024; 33 shares on April 6, 2025; 1,747 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:56 UTC |
Ladin Felicia ICFO, VP Fin & Admin, Treasurer
|
Tax withholdingCommon Stock | 13 | $0.94 | $12.22 |
DisclosureSEC source: 0001437749-23-009815 · rdgdoc.xml · nonDerivative · entry 2 Ladin Felicia I · CIK 0001632868 · CFO, VP Fin & Admin, Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41 F2 · kind: No stock was sold. On April 6 2023, in connection with the vesting of 34 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:56 UTC |
Ladin Felicia ICFO, VP Fin & Admin, Treasurer
|
Exercise / conversionCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009815 · rdgdoc.xml · nonDerivative · entry 1 Ladin Felicia I · CIK 0001632868 · CFO, VP Fin & Admin, Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.